Hepatopulmonary Syndrome Markedly Increases Mortality in Cirrhotic Patients
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish Powered byTelemed2U
Powered byTelemed2U

Hepatopulmonary Syndrome Markedly Increases Mortality in Cirrhotic Patients

Hepatopulmonary Syndrome (HPS) is a serious vascular complication of liver disease that markedly increases mortality. The median survival time in cirrhotic patients with HPS is ~ 10.6 months compared to 40.8 months in cirrhotic patients without HPS.

https://jumpshare.com/v/6Gmg5gIvxodJulbQ5pAk


Metadata